Urania Rappo

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas et al. · Cell · 2022 · 465 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Phage Consortia +10

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Urania Rappo, Sailaja Puttagunta, V. G. Shevchenko et al. · Open Forum Infectious Diseases · 2018 · 200 citations · Full text

Impact of Early Detection of Respiratory Viruses by Multiplex PCR Assay on Clinical Outcomes in Adult Patients

Urania Rappo, Audrey N. Schuetz, Stephen G. Jenkins et al. · Journal of Clinical Microbiology · 2016 · 168 citations · Full text

Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial

Nicholas Turner, Smitha Zaharoff, Heather A. King et al. · Trials · 2022 · 51 citations · Full text

Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections

Urania Rappo, Pedro González, Sailaja Puttagunta et al. · Journal of Global Antimicrobial Resistance · 2019 · 38 citations · Full text